CADL Candel Therapeutics, Inc.

Fundamentals / CIK 0001841387 / USD

Candel Therapeutics, Inc. reported $211.1M in total assets and a net loss of $99.14M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CADL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$5.95M$2.97M$0-$51.60MFY 2020 Revenue: $125KFY 2020 Net Income: -$17.68M2020FY 2021 Revenue: $125KFY 2021 Net Income: -$36.12M2021FY 2022 Revenue: $125KFY 2022 Net Income: -$18.79M2022FY 2023 Net Income: -$37.94M2023FY 2024 Net Income: -$55.18M2024FY 2025 Net Income: -$38.18M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $125K $125K $125K
Research & Development $30.50M $19.31M $24.51M $20.79M $15.18M $8.75M
Total Operating Expenses $48.27M $33.37M $38.39M $34.85M $25.85M $13.94M
Operating Income -$48.27M -$33.37M -$38.39M -$34.72M -$25.73M -$13.81M
EBITDA -$47.42M -$32.38M -$37.43M -$33.94M -$25.49M -$13.72M
Interest Income -- -- $2.08M $1.22M -- --
Interest Expense $2.12M $2.09M -$2.60M $1.71M -- --
Income Before Tax -$38.18M -$55.18M -- -- -- --
Income Tax Expense $0 $0 $0 $0 $0 --
Net Income -$38.18M -$55.18M -$37.94M -$18.79M -$36.12M -$17.68M
Basic EPS -$0.72 -$1.74 -$1.31 -$0.65 -$1.91 -$1.52
Diluted EPS -$0.72 -$1.74 -$1.31 -$0.65 -$1.91 -$1.52
Basic Shares Outstanding 53.0M 31.7M 28.9M 28.8M 18.9M 11.6M
Diluted Shares Outstanding 53.0M 31.7M 28.9M 28.8M 18.9M 11.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $15.59M $19.80M $9.84M $11.03M $8.46M $6.99M $4.02M $4.82M
Total Operating Expenses $22.98M $26.75M $16.28M $15.75M $13.21M $11.18M $8.13M $8.14M
Operating Income -$22.98M -$26.75M -$16.28M -$15.75M -$13.21M -$11.18M -$8.13M -$8.14M
EBITDA -$22.78M -$26.55M -$16.14M -$15.59M -$13.01M -$10.98M -$7.88M -$7.90M
Interest Expense $1.59M $1.57M $1.56M $1.42M $161K $236K $306K $390K
Net Income -$21.87M -$38.91M -$8.86M -$29.50M -$11.27M -$4.80M $7.38M -$14.07M
Basic EPS -$0.28 -$0.52 -$0.14 -- -$0.21 -$0.09 $0.15 --
Diluted EPS -$0.28 -$0.52 -$0.14 -- -$0.21 -$0.09 $0.13 --
Basic Shares Outstanding 77.4M 74.1M 62.4M -- 54.9M 51.5M 50.5M --
Diluted Shares Outstanding 77.4M 74.1M 62.4M -- 54.9M 51.5M 54.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $119.7M $102.7M $35.41M $70.06M $82.64M $35.05M
Cash & Short-Term Investments $119.7M $102.7M $35.41M $70.06M $82.64M $35.05M
Total Current Assets $121.4M $103.8M $36.80M $71.94M $84.94M $35.15M
Property, Plant & Equipment, Net $1.64M $2.19M $3.21M $4.42M $3.84M $2.79M
Other Non-Current Assets -- -- -- -- $424K $349K
Total Non-Current Assets $3.81M $3.06M $4.40M $5.75M $4.26M $3.14M
Total Assets $125.2M $106.9M $41.20M $77.69M $89.20M $38.28M
Accounts Payable $1.13M $237K $422K $380K $1.59M $921K
Short-Term Debt $0 $9.89M $8.89M -- -- --
Other Current Liabilities $89K $0 -- $48K $334K $187K
Total Current Liabilities $9.00M $37.53M $14.18M $5.62M $5.36M $4.71M
Long-Term Debt -- $1.73M $11.63M -- $560K $483K
Deferred Revenue (Non-Current) $89K $0 -- $144K -- $125K
Total Non-Current Liabilities $64.28M $3.01M $14.27M $24.36M $19.71M $8.07M
Total Liabilities $73.27M $40.54M $28.46M $29.98M $25.07M $12.78M
Total Debt (incl. Leases) $1.90M $12.60M $22.01M $1.95M $560K $483K
Common Stock $550K $469K $290K $290K $286K $116K
Retained Earnings -$230.4M -$192.2M -$137.0M -$99.09M -$80.30M -$44.17M
Total Stockholders' Equity $51.92M $66.33M $12.74M $47.71M $64.14M -$23.56M
Total Equity $51.92M $66.33M $12.74M $47.71M $64.14M -$23.56M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $203.1M $201.6M $194.8M $119.7M $86.96M $100.7M $92.17M $102.7M
Cash & Short-Term Investments $203.1M $201.6M $194.8M $119.7M $86.96M $100.7M $92.17M $102.7M
Total Current Assets $207.4M $204.2M $197.8M $121.4M $90.13M $103.6M $93.15M $103.8M
Property, Plant & Equipment, Net $1.90M $2.00M $2.08M $1.64M $1.36M $1.66M $1.97M $2.19M
Total Non-Current Assets $3.76M $3.99M $4.17M $3.81M $3.46M $2.36M $2.76M $3.06M
Total Assets $211.1M $208.1M $201.9M $125.2M $93.60M $106.0M $95.91M $106.9M
Accounts Payable $2.54M $5.15M $3.04M $1.13M $1.12M $1.95M $760K $237K
Short-Term Debt -- -- -- $0 $4.22M $6.70M $9.17M $9.89M
Other Current Liabilities $89K $89K $89K $89K -- -- -- $0
Total Current Liabilities $27.39M $12.69M $7.05M $9.00M $10.93M $14.71M $20.07M $37.53M
Long-Term Debt -- -- -- -- -- -- -- $1.73M
Deferred Revenue (Non-Current) $22K $45K $67K $89K -- -- -- $0
Total Non-Current Liabilities $52.13M $69.33M $56.84M $64.28M $2.54M $1.04M $1.16M $3.01M
Total Liabilities $79.52M $82.02M $63.89M $73.27M $13.47M $15.76M $21.23M $40.54M
Total Debt (incl. Leases) $1.57M $1.69M $1.80M $1.90M $6.23M $7.40M $10.01M $12.60M
Common Stock $786K $761K $733K $550K $550K $549K $493K $469K
Retained Earnings -$300.0M -$278.2M -$239.2M -$230.4M -$200.9M -$189.6M -$184.8M -$192.2M
Total Stockholders' Equity $131.6M $126.1M $138.0M $51.92M $80.12M $90.21M $74.67M $66.33M
Total Equity $131.6M $126.1M $138.0M $51.92M $80.12M $90.21M $74.67M $66.33M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$38.18M -$55.18M -$37.94M -$18.79M -$36.12M -$17.68M
Depreciation & Amortization $845K $990K $960K $778K $232K $91K
Stock-Based Compensation $3.82M $5.31M $3.09M $2.31M $2.96M $2.11M
Change in Payables $802K -$185K $45K -$1.21M $669K $289K
Operating Cash Flow -$38.31M -$27.02M -$34.24M -$31.42M -$22.22M -$9.07M
Capital Expenditure -$587K -$16K -$457K -$1.30M -$1.83M -$1.48M
Free Cash Flow -$38.90M -$27.04M -$34.70M -$32.72M -$24.05M -$10.55M
Purchases of Investments -- -- -- -- -- -$6.0K
Investing Cash Flow -$560K -$16K -$280K -$1.30M -$1.83M $38.45M
Financing Cash Flow $56.10M $94.28M -$121K $19.97M $71.80M $490K
Net Change in Cash $17.23M $67.24M -$34.65M -$12.74M $47.75M $29.87M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$21.87M -$38.91M -$8.86M -$46.87M $6.10M -$4.80M $7.38M -$14.07M
Depreciation & Amortization $200K $200K $149K $163K $200K $200K $245K $245K
Stock-Based Compensation $2.65M $2.86M $1.45M $1.29M $1.16M $1.05M $314K $1.24M
Change in Payables -$2.58M $2.38M $1.70M $33K -$744K $1.01M $507K -$56K
Operating Cash Flow -$23.12M -$17.18M -$18.04M -$10.57M -$10.24M -$8.89M -$8.62M -$5.81M
Capital Expenditure -$141K -$69K -$675K -$409K -$144K -$31K -$3.0K -$3.0K
Free Cash Flow -$23.26M -$17.25M -$18.71M -$10.98M -$10.38M -$8.92M -$8.62M -$5.82M
Investing Cash Flow -$141K -$69K -$675K -$409K -$117K -$31K -$3.0K -$3.0K
Common Stock Issued -- -- -- -- $0 $4.65M $384K --
Financing Cash Flow $24.81M $23.98M $93.81M $43.90M -$3.37M $17.44M -$1.87M $91.91M
Net Change in Cash $1.55M $6.73M $75.10M $32.92M -$13.72M $8.52M -$10.49M $86.10M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -27777.6% -20580.8% -11048.0%
Net Profit Margin -- -- -- -15035.2% -28899.2% -14144.0%
Return on Equity (ROE) -73.5% -83.2% -297.7% -39.4% -56.3% --
Return on Assets (ROA) -30.5% -51.6% -92.1% -24.2% -40.5% -46.2%
Current Ratio 13.49x 2.77x 2.59x 12.81x 15.84x 7.46x
Quick Ratio 13.31x 2.74x 2.50x 12.48x 15.41x 7.44x
Debt to Equity 0.04x 0.19x 1.73x 0.04x 0.01x --
Revenue Growth (YoY) -- -- -- 0.0% 0.0% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -75.3% -70.2% -39.4% -73.5% -28.4% -24.5% -53.0% -83.2%
Return on Assets (ROA) -47.0% -42.5% -27.0% -30.5% -24.3% -20.9% -41.3% -51.6%
Current Ratio 7.57x 16.09x 28.05x 13.49x 8.25x 7.04x 4.64x 2.77x
Quick Ratio 7.42x 15.89x 27.63x 13.31x 7.96x 6.84x 4.59x 2.74x
Debt to Equity 0.01x 0.01x 0.01x 0.04x 0.08x 0.08x 0.13x 0.19x
Net Income Growth (YoY) -- -- -220.1% -- -- -- -- --
EPS Growth (YoY) -- -- -193.3% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001841387) · from June 30, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:33 UTC · Open in terminal